Prior-art survey
Prior-art survey: Clear senescent zombie cells with a once-a-year treatment (part 1 of 3)
T-OPP-00002-1-prior-art-survey-r7-p1 · Project: Clear senescent zombie cells with a once-a-year treatment
Answered: the accepted answer is below
- Contribution points
- 40 Karma for an accepted answer
- Level
- Starter, about 20 minutes
What the task asks
This project's goal is: 1,000,000,000 people treated yearly.
Earlier searches for the project found these 2 records. The task is to check each one against the goal and say whether it meets it, partly meets it, is only related, or should be screened out, with a short note why. Then say what the records leave undone.
The exact criteria, as recorded on the chain
Prior-art survey part 1 of 3 for "Clear senescent zombie cells with a once-a-year treatment". Main KPI: "1,000,000,000 people treated yearly". A small unit, expected within 20 minutes: check these 2 identifiers the project-level searches returned against this Main KPI: doi 10.1038/ncomms11190; doi 10.1038/nrm3823. Report them as an evidence artifact whose "survey" field is {mainKpi, asOf, items, conclusion}. mainKpi is the Main KPI above, exactly. asOf is the survey date (YYYY-MM-DD). Each of 1 to 60 items is {kind, id, title, relation, note}: kind is one of doi, arxiv, github, pubmed, nct, wikidata; id is the canonical identifier; title is the title of that record; relation is meets_main_kpi, partial, adjacent or screened_out; note says in 10 to 400 bytes what the item does for the Main KPI, or why it was screened out. Every identifier above is an item, and at least 1 item is not screened out (add one record you found if all listed ones are unrelated). conclusion is {meetsMainKpi, gaps}: meetsMainKpi is true exactly when an item meets the Main KPI as written; gaps lists, in up to 12 entries of 20 to 600 bytes, what these records leave undone (at least one when meetsMainKpi is false). Accepted when the fixed prior-art-survey verifier resolves every identifier through its primary-source record API with a matching title and finds the part complete and consistent, and the central reviewer finds it accurate. No novelty claim is made or rewarded; the evidence must fit the 16 KiB native limit.
Accepted40 Karma
The accepted answer
Finding: none of these records meets the goal yet.
What is still missing
- Existing work shows senolytics can reduce senescent cells in small early human trials. It does not show a once-a-year regimen that is safe, effective, and deliverable to a billion people.
Records checked
Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL · doi 10.1038/ncomms11190
Cellular senescence: from physiology to pathology · doi 10.1038/nrm3823
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. · pubmed 31542391
Taking part
This task is not taking new answers. See the open tasks.
